Add BrightSurf on Google Email

Study: Time-restricted eating may improve health of adults with metabolic syndrome

A recent study found that limiting food consumption within a 10-hour window per day improved key indicators of heart health in adults with metabolic syndrome. The study demonstrated significant reductions in blood sugar and cholesterol levels, as well as lower levels of hemoglobin A1c, a marker of long-term blood sugar management.

SourceUniversity of California - San Diego·JournalAnnals of Internal Medicine·DateSep 30, 2024

Time-restricted eating associated with greater blood sugar control and fat loss than standard nutrition counseling

A randomized controlled trial found that time-restricted eating (TRE) led to greater improvements in glucose control, weight loss, and fat reduction compared to standard nutrition counseling in adults with metabolic syndrome. TRE resulted in a lower risk of muscle mass loss during weight loss.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateSep 30, 2024

Myths about intermittent fasting, debunked

Research debunks four common myths about intermittent fasting: it does not lead to a poor diet, cause eating disorders, excessive lean muscle mass loss, or affect sex hormones. Studies show both types of intermittent fasting (alternate-day and time-restricted) are safe despite popular misconceptions.

SourceUniversity of Illinois Chicago·JournalNature Reviews Endocrinology·DateJun 24, 2024

Exposure to mixtures of endocrine-disrupting chemicals during pregnancy is associated with higher odds of metabolic syndrome in children

A new study found that prenatal exposure to a combination of endocrine-disrupting chemicals is associated with poorer metabolic health in childhood, increasing the risk of metabolic syndrome in adulthood. Mixtures of metals, PFAS, and organochlorine pesticides were linked to higher risks.

Does worsening metabolic syndrome increase the risk of developing cancer?

A new study published in CANCER reveals that individuals with worsening metabolic syndrome are at a higher risk of developing various types of cancer. The study followed 44,115 adults in China and found that those with an elevated-increasing pattern of metabolic syndrome scores had a significantly higher risk of developing multiple typ...

SourceWiley·JournalCancer·DateMar 11, 2024

Women with high-risk HPV and metabolic syndrome have almost three times risk for mortality, York University researchers find

Researchers at York University found that women with both high-risk human papillomavirus (HPV) and metabolic syndrome are at a significantly higher risk of mortality. The study analyzed data from over 5,000 individuals and found that those with both conditions had a 2.6 times higher risk for mortality than those without either condition.

SourceYork University·JournalPLOS ONE·TypeData/statistical analysis·DateMar 8, 2024

Factors that increase risk of frailty in old age are different in men and women

A study analyzing ELSA data found that osteoporosis, heart disease, and poor hearing increased frailty risk in men, while high fibrinogen levels, diabetes, and stroke were linked to higher risks in women. This highlights the importance of gender-specific action plans and intervention for older people.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalArchives of Gerontology and Geriatrics·DateFeb 28, 2024

Daily intake of tree nuts, including pistachios, does not lead to weight gain, body fat gain, or changes in energy intake in Millennials

Millennial-aged adults who snack on pistachios and other tree nuts experience better weight control and more efficient use of dietary fat as an energy source. The study's results support the inclusion of tree nuts as part of a healthy self-care routine in 2024.

SourceAmerican Pistachio Growers·JournalNutrients·TypeRandomized controlled/clinical trial·DateFeb 7, 2024

Stress, via inflammation, is linked to metabolic syndrome

A new study found that stress drives up inflammation in the body, which is linked to metabolic syndrome. Stress management techniques may be a way to improve biological health outcomes. The research suggests that reducing inflammation can help mitigate the connection between stress and metabolic syndrome.

SourceOhio State University·JournalBrain Behavior & Immunity - Health·TypeData/statistical analysis·DateJan 12, 2024

Liver cancer rates increase in each successive generation of Mexican Americans, study finds

A study by the Keck School of Medicine of USC found that liver cancer risk increases with each successive generation of Mexican Americans, particularly among men. The research analyzed data from over 30,000 participants and found third-generation Mexicans to be 66% more likely to develop liver cancer than first-generation individuals.

SourceKeck School of Medicine of USC·JournalCancer·TypeMeta-analysis·DateNov 20, 2023

Exercise-mimicking drug sheds weight, boosts muscle activity in mice

A new exercise-mimicking drug, SLU-PP-332, has shown promising results in obese mice, leading to weight loss and increased muscle activity without increasing physical activity. The drug works by boosting a natural metabolic pathway, making the body act like it is training for a marathon, resulting in faster metabolism of fat.

SourceUniversity of Florida·JournalJournal of Pharmacology and Experimental Therapeutics·TypeExperimental study·DateSep 25, 2023

Schizophrenia genetic risk factor impairs mitochondrial function

Researchers have discovered a possible link between mitochondrial function and schizophrenia, highlighting impaired energy production as a key factor in its development. Mitochondrial dysregulation can cause psychiatric symptoms and disorders, and its effects are seen not only in the brain but also in other cells, such as kidney cells.

SourceRutgers University·JournalScience Advances·TypeExperimental study·DateAug 16, 2023

First bioavailable compound that specifically inhibits free radical production in mitochondria prevents and treats metabolic syndrome in mice

Researchers at Buck Institute for Research on Aging developed a bioavailable compound that selectively inhibits free radical production in mitochondria, preventing and treating metabolic syndrome in mice. The compound, S1QEL1.719, decreases fat accumulation, improves glucose tolerance, and normalizes fasting insulin levels.

SourceBuck Institute for Research on Aging·JournalFree Radical Biology and Medicine·TypeExperimental study·DateJul 9, 2023

Metformin's role in preventing metabolic syndrome during androgen deprivation therapy: a Phase II study

A randomized phase II study found that adding metformin to androgen deprivation therapy did not reduce the risk of metabolic syndrome or improve PSA response in patients with advanced prostate cancer. Metformin showed some antitumor effects through mTOR inhibition, but these were not significant.

SourceImpact Journals LLC·JournalOncotarget·TypeRandomized controlled/clinical trial·DateJun 20, 2023

Heavy drinking poses even greater risk for one in three Americans

A new study from Keck Medicine of USC reveals that heavy alcohol use may be more damaging to the liver for people with metabolic syndrome, more than doubling the risk of advanced liver disease. This condition, characterized by symptoms such as abdominal fat, high blood pressure, and high cholesterol, affects over one in three Americans.

SourceUniversity of Southern California - Health Sciences·JournalAnnals of Internal Medicine·TypeData/statistical analysis·DateMay 11, 2023

Metabolic syndrome with heavy alcohol use may have contributed to recent surge in alcoholic liver disease-related mortality

Researchers found that heavy alcohol use and the presence of metabolic syndrome were associated with a higher risk for advanced liver disease. The study suggests an increasing interaction effect between MetS, heavy alcohol use, and a recent surge in alcoholic liver disease-related mortality.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeSurvey·DateMay 8, 2023

Community co-design model targets Indigenous diet and diabetes

A community co-design model targeting Indigenous diet and diabetes uses a ketogenic eating plan, which aligns with pre-colonisation eating patterns for Australian Indigenous people. The project aims to explore how Indigenous peoples are advantaged by adopting a keto diet and monitor physiological, social, and economic outcomes.

SourceFlinders University·JournalNature Medicine·TypeObservational study·DateFeb 15, 2023

Oncotarget | Expression of p-STAT3 and c-Myc correlates with P2-HNF4α expression in nonalcoholic fatty liver disease (NAFLD)

Researchers found that P2-HNF4α expression is associated with p-STAT3 and c-Myc expression in NAFLD patients, suggesting potential biomarkers for hepatocellular carcinoma (HCC) risk. Additionally, p-STAT3 expression was linked to hypertension, while c-Myc expression was associated with advanced fibrosis.

SourceImpact Journals LLC·JournalOncotarget·TypeObservational study·DateDec 6, 2022